LEADER 02189nam  2200601 a 450 
001 9910457768903321
005 20200520144314.0
010   $a1-61668-893-9
035   $a(CKB)2550000000048005
035   $a(EBL)3020107
035   $a(SSID)ssj0000568971
035   $a(PQKBManifestationID)12244715
035   $a(PQKBTitleCode)TC0000568971
035   $a(PQKBWorkID)10541263
035   $a(PQKB)10903293
035   $a(MiAaPQ)EBC3020107
035   $a(Au-PeEL)EBL3020107
035   $a(CaPaEBR)ebr10675115
035   $a(OCoLC)923662781
035   $a(EXLCZ)992550000000048005
100   $a20100322d2010      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aDrug targeting by magnetically responsive colloids$b[electronic resource] /$fJose? L. Arias
210   $aNew York $cNova Biomedical$dc2010
215   $a1 online resource (202 p.)
225 1 $aPharmacology-research, safety testing and regulation
300   $aDescription based upon print version of record.
311   $a1-61668-484-4 
320   $aIncludes bibliographical references and index.
327   $aDesign and improvement of magnetic colloids -- Properties of magnetic colloids to be tailored for drug delivery -- Biological fate and toxicity -- Drug delivery by magnetic colloids -- Multifunctional nanoplatforms based on magnetic colloids -- Biomedical applications of magnetic colloids non-related to drug delivery.
410  0$aPharmacology-research, safety testing, and regulation series.
606   $aDrug delivery systems
606   $aColloids in medicine
606   $aNanoparticles$xTherapeutic use
606   $aMagnetotherapy
608   $aElectronic books.
615  0$aDrug delivery systems.
615  0$aColloids in medicine.
615  0$aNanoparticles$xTherapeutic use.
615  0$aMagnetotherapy.
676   $a615/.6
700   $aArias$b Jose? L$0887871
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910457768903321
996   $aDrug targeting by magnetically responsive colloids$91983248
997   $aUNINA